Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Deferred Taxes: 2020-2023

Historic Deferred Taxes for Cellebrite DI (CLBT) over the last 3 years, with Dec 2023 value amounting to $2.3 million.

  • Cellebrite DI's Deferred Taxes rose 3854.10% to $2.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.1 million, marking a year-over-year increase of 314.26%. This contributed to the annual value of -$4.0 million for FY2024, which is 178.34% down from last year.
  • According to the latest figures from Q4 2023, Cellebrite DI's Deferred Taxes is $2.3 million, which was down 3.50% from $2.4 million recorded in Q3 2023.
  • Over the past 5 years, Cellebrite DI's Deferred Taxes peaked at $2.4 million during Q3 2023, and registered a low of -$4.1 million during Q4 2020.
  • For the 3-year period, Cellebrite DI's Deferred Taxes averaged around $91,250, with its median value being -$79,500 (2022).
  • As far as peak fluctuations go, Cellebrite DI's Deferred Taxes crashed by 785.07% in 2022, and later surged by 3,854.10% in 2023.
  • Quarterly analysis of 4 years shows Cellebrite DI's Deferred Taxes stood at -$4.1 million in 2020, then surged by 106.53% to $269,000 in 2021, then tumbled by 122.68% to -$61,000 in 2022, then soared by 3,854.10% to $2.3 million in 2023.
  • Its Deferred Taxes was $2.3 million in Q4 2023, compared to $2.4 million in Q3 2023 and -$98,000 in Q2 2023.